Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ask Vendit Off-Topic Questions -- Ignore unavailable to you. Want to Upgrade?

To: Walkingshadow who wrote (8089)	4/22/2005 9:02:18 AM
From: Vendit™	Read Replies (1) \| Respond to of 8752

Your chart clearly shows the lower gap formed yesterday. 139.142.147.22

To: Walkingshadow who wrote (8089)	4/22/2005 9:12:13 AM
From: Vendit™	Read Replies (2) \| Respond to of 8752

AMGN 139.142.147.218 AMGEN NET UP 24%; BOOSTS '05 OUTLOOK Biotechnology company earns $854 million, or 67c a share, on strong product sales. Excluding items, Amgen earns 72c cents a share, which tops analyst estimates of 68c. Revenue rises 20% to $2.83 billion but falls short of estimates of $2.87 billion.